CEFOXITIN FOR INJECTION USP POWDER FOR SOLUTION Canada - English - Health Canada

cefoxitin for injection usp powder for solution

pfizer canada ulc - cefoxitin (cefoxitin sodium) - powder for solution - 1g - cefoxitin (cefoxitin sodium) 1g - cephamycins

CEFOXITIN FOR INJECTION USP POWDER FOR SOLUTION Canada - English - Health Canada

cefoxitin for injection usp powder for solution

pfizer canada ulc - cefoxitin (cefoxitin sodium) - powder for solution - 2g - cefoxitin (cefoxitin sodium) 2g - cephamycins

CEFOXITIN injection, powder, for solution United States - English - NLM (National Library of Medicine)

cefoxitin injection, powder, for solution

wg critical care, llc - cefoxitin sodium (unii: q68050h03t) (cefoxitin - unii:6oev9dx57y) - treatment cefoxitin for injection, usp is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. (1) lower respiratory tract infections , including pneumonia and lung abscess, caused by streptococcus pneumoniae, other streptococci (excluding enterococci, e.g., enterococcus faecalis [formerly streptococcus faecalis]), staphylococcus aureus (including penicillinase-producing strains), escherichia coli, klebsiella species, haemophilus influenzae, and bacteroides species. (2) urinary tract infections caused by escherichia coli, klebsiella species, proteus mirabilis, morganella morganii, proteus vulgaris and providencia species (including p. rettgeri ). (3) intra-abdominal infections , including peritonitis and intra-abdominal abscess, caused by escherichia coli, klebsiella species, bacteroides species including bacteroides fragilis, and clostridium species. (4) gynecological infections , including endometritis,

CEFOXITIN- cefoxitin sodium powder, for solution United States - English - NLM (National Library of Medicine)

cefoxitin- cefoxitin sodium powder, for solution

fresenius kabi usa, llc - cefoxitin sodium (unii: q68050h03t) (cefoxitin - unii:6oev9dx57y) - cefoxitin for injection, usp is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. appropriate culture and susceptibility studies should be performed to determine the susceptibility of the causative organisms to cefoxitin for injection, usp. therapy may be started while awaiting the results of these studies. in randomized comparative studies, cefoxitin for injection, usp and cephalothin were comparably safe and effective in the management of infections caused by gram-positive cocci and gram-negative rods susceptible to the cephalosporins. cefoxitin for injection, usp has a high degree of stability in the presence of bacterial beta-lactamases, both penicillinases and cephalosporinases. many infections caused by aerobic and anaerobic gram-negative bacteria resistant to some cephalosporins respond to cefoxitin for injection, usp. similarly, many infections caused by aerobic and anaerobic bacteria resistant to some penicil

CEFOXITIN injection powder for solution United States - English - NLM (National Library of Medicine)

cefoxitin injection powder for solution

apotex corporation - cefoxitin sodium (unii: q68050h03t) (cefoxitin - unii:6oev9dx57y) - cefoxitin 1 g

Convenia European Union - English - EMA (European Medicines Agency)

convenia

zoetis belgium sa - cefovecin (as sodium salt) - antibacterials for systemic use - dogs; cats - dogsfor the treatment of skin and soft-tissue infections including pyoderma, wounds and abscesses associated with staphylococcus pseudintermedius, β-haemolytic streptococci, escherichia coli and / or pasteurella multocida.for the treatment of urinary-tract infections associated with escherichia coli and / or proteus spp.as adjunctive treatment to mechanical or surgical periodontal therapy in the treatment of severe infections of the gingiva and periodontal tissues associated with porphyromonas spp. and prevotella spp.catsfor the treatment of skin and soft-tissue abscesses and wounds associated with pasteurella multocida, usobacterium spp., bacteroides spp., prevotella oralis, β-haemolytic streptococci and / or staphylococcus pseudintermedius.for the treatment of urinary-tract infections associated with escherichia coli.

Hospira™ Cefoxitin Sodium New Zealand - English - Medsafe (Medicines Safety Authority)

hospira™ cefoxitin sodium

pfizer new zealand limited - cefoxitin sodium 1.051 g equivalent to cefoxitin 1 g - powder for injection - 1 g - active: cefoxitin sodium 1.051 g equivalent to cefoxitin 1 g - hospira™ cefoxitin sodium powder for injection is indicated for the treatment of the following infections when due to susceptible organisms (see microbiology) peritonitis and other intraabdominal and intra-pelvic infections, female genital tract infections, septicaemia, endocarditis, urinary tract infections, respiratory tract infections, bone and joint infections, skin and skin structure infections. hospira™ cefoxitin sodium powder for injection has a high degree of stability against betalactamase and is therefore effective against beta-lactamase producing organisms resistant to penicillins or cephalosporins. it can also be used in mixed infections provided that the organisms are sensitive to it. hospira™ cefoxitin sodium powder for injection can be used as adjunctive therapy in the surgical treatment of infections including abscesses, infection complicating hollow viscous perforations, cutaneous infections and infections of serous surfaces whether caused by aerobes, mixed aerobes and anaerobes, or anaerobes.

CONVENIA- cefovecin sodium injection, powder, lyophilized, for solution United States - English - NLM (National Library of Medicine)

convenia- cefovecin sodium injection, powder, lyophilized, for solution

zoetis inc. - cefovecin sodium (unii: dl8q24959p) (cefovecin - unii:0d1ol46zie) - cefovecin 80 mg in 1 ml - dogs convenia is indicated for the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of staphylococcus intermedius and streptococcus canis (group g). cats convenia is indicated for the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of pasteurella multocida . convenia is contraindicated in dogs and cats with known allergy to cefovecin or to β-lactam (penicillins and cephalosporins) group antimicrobials. anaphylaxis has been reported with the use of this product in foreign market experience. if an allergic reaction or anaphylaxis occurs, convenia should not be administered again and appropriate therapy should be instituted. anaphylaxis may require treatment with epinephrine and other emergency measures, including oxygen, intravenous fluids, intravenous antihistamine, corticosteroids, and airway management, as clinically indicated. adverse reactions may require prolonged treatment due to the prol

CONVENIA VETERINARY Israel - English - Ministry of Health

convenia veterinary

zoetis israel holding b.v., israel - cefovicin as sodium salt - powder and solvent for solution for injection - cefovicin as sodium salt 80 mg/dose - dogs : for the treatment of skin and soft tissue infections including pyoderma wounds and abscesses associated with staphylococcus intermedius beta-haemolytic streptococci escherichia coli and/or pasteurella multocida. for the treatment of urinary tract infections associated with escherichia coli and/or proteus spp.as adjunctive treatment to mechanical or surgical periodontal therapy of severe infections of the gingival and periodontal tissues associated with porphyromonas spp. and prevotella spp. cats : for the treatment of skin and soft tissue abscesses and wounds associated with pasteurella multocida fusobacterium spp. bacteroides spp. prevotella oralis beta-haemolytic streptococci and/or staphylococcus intermedius. for the treatment of urinary tract infections associated with escherichia coli.